Filter
801
Text search:
rifampicin
Featured
111
241
Language
Document type
566
104
61
28
13
12
9
4
2
1
1
Countries / Regions
57
56
32
23
23
19
16
14
13
13
12
12
12
12
11
10
9
9
9
9
9
8
7
7
6
5
5
5
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
298
109
18
18
16
12
5
Toolboxes
352
75
39
27
26
15
10
5
5
4
4
3
3
2
1
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
6th edition
Accessed at March 2014
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Accessed at March 2014
guidance for health managers, health workers, and activists
Trainer’s Manual
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
